ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Menlo Therapeutics Inc

Menlo Therapeutics Inc (MNLO)

1.35
0.00
(0.00%)
Closed February 03 3:00PM
0.00
0.00
(0.00%)

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
1.35
Bid
1.36
Ask
1.37
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
1.35
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
13,957,000
Dividend Yield
-
PE Ratio
-1.15
Earnings Per Share (EPS)
-2.04
Revenue
424k
Net Profit
-28.45M

About Menlo Therapeutics Inc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-

MNLO Latest News

Robbins Geller Rudman & Dowd LLP Announce Proposed Settlement in the Menlo Therapeutics Inc. Securities Settlement

The following statement is being issued by Robbins Geller Rudman & Dowd LLP regarding the Menlo Therapeutics Inc. Securities Settlement: SUPERIOR COURT OF THE STATE OF CALIFORNIA COUNTY OF...

Menlo Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results

REDWOOD CITY, Calif., March 03, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the...

Menlo Therapeutics Announces Results from Phase 2 Trial of Serlopitant in Patients with Chronic Pruritus of Unknown Origin

REDWOOD CITY, Calif., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company, today announced results from its Phase 2 clinical trial...

Menlo Therapeutics to Host Conference Call Tomorrow to Discuss Results from Phase 2 Trial of Serlopitant in Patients with Chr...

REDWOOD CITY, Calif., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company, today announced it will host a conference call and webcast...

Menlo Therapeutics Announces Publication of Phase 2 Results for Serlopitant for the Treatment of Pruritus Associated with Pso...

REDWOOD CITY, Calif., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment...

Menlo Therapeutics CEO to Participate in Fireside Chat at the Piper Jaffray 31st Annual Healthcare Conference

REDWOOD CITY, Calif., Nov. 27, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment...

SHAREHOLDER ALERT: WeissLaw LLP Investigates Foamix Pharmaceuticals Ltd.

SHAREHOLDER ALERT: WeissLaw LLP Investigates Foamix Pharmaceuticals Ltd. PR Newswire NEW YORK, Nov. 12, 2019 NEW YORK, Nov. 12, 2019 /PRNewswire/ -- WeissLaw LLP is investigating possible...

Menlo Therapeutics Reports Third Quarter 2019 Financial Results and Provides Program Updates

REDWOOD CITY, Calif., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment...

Menlo Therapeutics Announces Completion of Enrollment in Two Phase 3 Trials of Serlopitant in Prurigo Nodularis

- Pivotal results expected in March/April 2020 - - Details of the program to be reviewed at company’s Investor Day today in NY - REDWOOD CITY, Calif., Oct. 29, 2019 (GLOBE NEWSWIRE) -- Menlo...

Menlo Therapeutics to Host Investor Day October 29, 2019

-Management to Review Late Stage Development, NDA-readiness and Commercial Opportunity of Serlopitant- -Discussion to Feature two Prominent Key Opinion Leaders Well Versed in the Unmet Needs of...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

MNLO - Frequently Asked Questions (FAQ)

What is the current Menlo Therapeutics share price?
The current share price of Menlo Therapeutics is US$ 1.35
How many Menlo Therapeutics shares are in issue?
Menlo Therapeutics has 13,957,000 shares in issue
What is the market cap of Menlo Therapeutics?
The market capitalisation of Menlo Therapeutics is USD 18.84M
What is the 1 year trading range for Menlo Therapeutics share price?
Menlo Therapeutics has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Menlo Therapeutics?
The price to earnings ratio of Menlo Therapeutics is -1.15
What is the cash to sales ratio of Menlo Therapeutics?
The cash to sales ratio of Menlo Therapeutics is 77.3
What is the reporting currency for Menlo Therapeutics?
Menlo Therapeutics reports financial results in USD
What is the latest annual turnover for Menlo Therapeutics?
The latest annual turnover of Menlo Therapeutics is USD 424k
What is the latest annual profit for Menlo Therapeutics?
The latest annual profit of Menlo Therapeutics is USD -28.45M
What is the registered address of Menlo Therapeutics?
The registered address for Menlo Therapeutics is 1521 CONCORD PIKE SUITE 201, WILMINGTON, DELAWARE, 19810
What is the Menlo Therapeutics website address?
The website address for Menlo Therapeutics is vynetherapeutics.com
Which industry sector does Menlo Therapeutics operate in?
Menlo Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AALAmerican Airlines Group Inc
US$ 16.92
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74.4033
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.88
(0.00%)
0
AACGATA Creativity Global
US$ 0.79325
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 16.92
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74.4033
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.88
(0.00%)
0
AACGATA Creativity Global
US$ 0.79325
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 16.92
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74.4033
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.88
(0.00%)
0
AACGATA Creativity Global
US$ 0.79325
(0.00%)
0

Discussion

View Full Feed
lakers17 lakers17 2 minutes ago
Crypto BTC now $95,000 and was $91,000. Going to be an ugly stock day today too.
ATLnsider ATLnsider 2 minutes ago
barnstormer, it’s always good to see your posts too.

I think the confusion for some is, confusing who owns the building and land versus who owns the Sawston Facility. It’s hard for some to separate, in their minds, and to distinguish who owns the building and the land, versus who own
CDMO
9Coastal 9Coastal 8 minutes ago
A worthy point you make "Their intentions became plenty obvious when they committed the biggest reneg ever seen on their previous promises re: their intentions what to do with patents.". Nevertheless, this has been and will continue to be an interesting watch..
VPLM
Peeteman Peeteman 9 minutes ago
You’re right. However, you also have 600 million shares currently restricted. When do they become unrestricted. Also, 415 million more authorized shares that can become outstanding. Still total common share amount is a drop in the hat compared to other otc companies out there with no income and 10 b
AXXA
SkeBallLarry SkeBallLarry 10 minutes ago
Panama has agreed to allow U.S. Navy ships free passage through the Panama Canal after Secretary of State Marco Rubio’s visit. It will also terminate its Panama Canal deal with China and exit China’s 2017 "Belt and Road Initiative."

https://x.com/JDunlap1974/status/1886294598747627585
SkeBallLarry SkeBallLarry 11 minutes ago
Panama has agreed to allow U.S. Navy ships free passage through the Panama Canal after Secretary of State Marco Rubio’s visit. It will also terminate its Panama Canal deal with China and exit China’s 2017 "Belt and Road Initiative."

https://x.com/JDunlap1974/status/1886294598747627585
SkeBallLarry SkeBallLarry 12 minutes ago
Panama has agreed to allow U.S. Navy ships free passage through the Panama Canal after Secretary of State Marco Rubio’s visit. It will also terminate its Panama Canal deal with China and exit China’s 2017 "Belt and Road Initiative."

https://x.com/JDunlap1974/status/1886294598747627585
jog49 jog49 12 minutes ago
"So now we wait for the Senate to confirm Bill."

Some here qualify as world class "waiters", and not the kind in restaurants!
FNMA
Tahoe2468 Tahoe2468 13 minutes ago
Any idea how much Sigma Corp in Bolivia is worth or sales a year ? Just curious how big they are... ??? 
KRTL
1hunglo 1hunglo 15 minutes ago
The Senate will vote on RFK jr’s confirmation Tuesday, I hope he is approved. He’s the best man for the job imo.
RDGL
wimike wimike 16 minutes ago
Baxers Thank you so much for your story and well wishes. She is 72 and they told her she will be sore for many months. She still works full-time (from home) and sat out the first 6 weeks.
She did go through rehab. They also gave her exercises to follow and sent home a unit for exercising he
NWBO
9Coastal 9Coastal 16 minutes ago
Interesting point. Appreciate.
VPLM
Peeteman Peeteman 20 minutes ago
All we know as shareholders is what the company tells us. Stock repurchase program put in place; no stock buybacks by company as of last financial statement; and debts being repaid which probably include derivative financing and may or may not have clauses in them that don’t allow company to repurch
AXXA
9Coastal 9Coastal 23 minutes ago
Appreciate your findings. What is the link to this report. I want to view also.. thx much.
VPLM
ElectricMountain53 ElectricMountain53 27 minutes ago
So, in short: the outlook for LW is very cloudy still, nothing in the near term, again some more testing...Same story all over again so??
Or they just missed the boat because of ML...
Is there anything positive on the horizon perhaps? Please enlighten us..
LWLG
LVerstee LVerstee 29 minutes ago
The person who funded his "travel" should rethink the value of the purchase made that was supposed to enable this "travel."
ITUP
ZeusOnSol ZeusOnSol 29 minutes ago
Welcome to Zeus token on Solana, this is a CTO (Community Take Over) since the original creator rugged the coin after grossing more than $262,000 in profits.

https://t.co/QSi6I81xF7

https://t.co/6PxsAIaTfn

https://pbs.twimg.com/media/Giv-ju0XgAAHkuN?forma
QVHE1XRU6BJBRCP
wagner wagner 30 minutes ago
Germany
Already a small upgap👀👀👀👀


Maybe it works 
NB
sentiment_stocks sentiment_stocks 31 minutes ago
Pretty sure Northwest still owns about 17 acres… the rest is owned by Huawei. But Northwest has a 20 year lease at a great rate, and that lease can be renewed for (I think) the same rate for another 20 years at the end.
NWBO
ATLnsider ATLnsider 34 minutes ago
You’re on the B team (Junior varsity). The game is over, and the 7 collusive Market Markets, hedge funds and short sellers, are clearing their bench, putting in the 3rd string FUDsters and admitting defeat.

You’ll get a few garbage minutes, but no one is paying attention or watching y
NWBO
One11 One11 35 minutes ago
Let's go parabolic!
MGON
barnstormer barnstormer 35 minutes ago
ATL, always good to see you making an appearance. There was a reference in the 2022 10-K regarding a purchase by Huawei that was a little confusion regarding ownership of the Sawston Facility, so spent some time with AI trying to clarify who owned what. If correct, appears that NWBO still owns 474 a
NWBO
Nrdc92 Nrdc92 36 minutes ago
That sums up the Proto/Jeunke/X camp perfectly. What is plainly evident and factually supported is to be distrusted, while unverifiable, pie-in-the-sky, peyote-induced prognostications are to be embraced and all non-believers demonized. 

Where have I seen this playbook before???
LWLG
doraemi doraemi 38 minutes ago
What is the Phone Number to Speak with a Allegiant Airlines Representative for Flight Reservations?
The best way to speak directly to a Allegiant Airlines customer service agent is by calling their dedicated line. Dial 1-8(0)0-514-3935 for immediate assistance.
Having the correct conta
LVerstee LVerstee 38 minutes ago
@RealDutch you are not gullible. You are also no genuis. You are just a useful TOOL.
ITUP

Your Recent History

Delayed Upgrade Clock